Pazopanib

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2592 publications

CT Perfusion Blood Flow Provides an Early Response Marker for Progression-free Survival in a Prospective Randomized Clinical Trial of Metastatic Renal Cell Carcinoma.

CT Perfusion Blood Flow Provides an Early Response Marker for Progression-free Survival in a Prospective Randomized Clinical Trial of Metastatic Renal Cell Carcinoma.

Journal: Technology in cancer research & treatment

Published: June 17, 2026

Correction: Combined antitumor activity of [177Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein.

Correction: Combined antitumor activity of [177Lu]Lu-FAPI-2286 and pazopanib in a sarcoma model: a preclinical theranostic study targeting fibroblast activation protein.

Journal: EJNMMI research

Published: April 28, 2026

Severe Metabolic Decompensation in Metastatic Sarcomatoid Renal Cell Carcinoma During Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review.

Severe Metabolic Decompensation in Metastatic Sarcomatoid Renal Cell Carcinoma During Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review.

Journal: Diagnostics (Basel, Switzerland)

Published: April 27, 2026

Machine Learning-Guided Survival Prediction and Treatment Sequencing in Advanced Soft Tissue Sarcoma Beyond Second-Line Therapy: A Retrospective Cohort Study.

Machine Learning-Guided Survival Prediction and Treatment Sequencing in Advanced Soft Tissue Sarcoma Beyond Second-Line Therapy: A Retrospective Cohort Study.

Journal: Oncology and therapy

Published: April 21, 2026

Complete Metabolic Remission in Metastatic BCOR-Altered Undifferentiated Round Cell Sarcoma Following Sequential Multimodal Therapy With Vincristine-Doxorubicin-Cyclophosphamide (VDC) Chemotherapy and Pazopanib Maintenance: A Case Report.

Complete Metabolic Remission in Metastatic BCOR-Altered Undifferentiated Round Cell Sarcoma Following Sequential Multimodal Therapy With Vincristine-Doxorubicin-Cyclophosphamide (VDC) Chemotherapy and Pazopanib Maintenance: A Case Report.

Journal: Cureus

Published: April 20, 2026

Recurrent intracranial hemorrhage without brain metastasis after VEGFR TKI rechallenge in metastatic renal cell carcinoma: a case report and literature review.

Recurrent intracranial hemorrhage without brain metastasis after VEGFR TKI rechallenge in metastatic renal cell carcinoma: a case report and literature review.

Journal: Frontiers in oncology

Published: April 17, 2026

Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma.

Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma.

Journal: JAMA network open

Published: April 15, 2026

Optimizing Sequential Targeted Therapies in Advanced Renal Cell Carcinoma Using Patient-Derived Orthotopic Xenograft Mouse Avatars.

Optimizing Sequential Targeted Therapies in Advanced Renal Cell Carcinoma Using Patient-Derived Orthotopic Xenograft Mouse Avatars.

Journal: Cancers

Published: April 12, 2026

Recurrent Radiation-Induced Angiosarcoma of the Breast Without Distant Metastasis: A Case Report.

Recurrent Radiation-Induced Angiosarcoma of the Breast Without Distant Metastasis: A Case Report.

Journal: Cureus

Published: April 09, 2026

A systematic review on clinical pharmacokinetics and pharmacodynamics of antiangiogenic tyrosine kinase inhibitors (TKIs) with high TDM scores.

A systematic review on clinical pharmacokinetics and pharmacodynamics of antiangiogenic tyrosine kinase inhibitors (TKIs) with high TDM scores.

Journal: Expert review of anticancer therapy

Published: April 08, 2026

Durable Disease Control in Disseminated Primary Splenic Leiomyosarcoma Treated With Sequential Gemcitabine-Docetaxel and Pazopanib Therapy: A Case Report.

Durable Disease Control in Disseminated Primary Splenic Leiomyosarcoma Treated With Sequential Gemcitabine-Docetaxel and Pazopanib Therapy: A Case Report.

Journal: Cureus

Published: April 06, 2026

Neurofibromatosis type 1 with bladder neurofibroma followed by retroperitoneal malignant peripheral nerve sheath tumor: a case report.

Neurofibromatosis type 1 with bladder neurofibroma followed by retroperitoneal malignant peripheral nerve sheath tumor: a case report.

Journal: Urology case reports

Published: March 26, 2026

Showing 1-12 of 2,592

Last Updated: 06/30/2026